Literature DB >> 8334512

Acute, chronic and differential effects of several anesthetic barbiturates on glutamate receptor activation in neuronal culture.

Z Cai1, P P McCaslin.   

Abstract

The acute and chronic effects of several anesthetic barbiturates, in therapeutic concentrations, on the excitatory amino acid (EAA)-induced elevation of intracellular calcium levels ([Ca2+]i) were examined in neuronal tissue culture. The ultrashort-acting barbiturate, thiamylal, was effective in blocking elevations of [Ca2+]i induced by kainate, N-methyl-D-aspartate (NMDA), and quisqualate or by membrane depolarization with 40 mM KCl. The structurally similar barbiturate, secobarbital which differs from thiamylal only by having an oxygen in place of a sulfur, was able to block elevations induced by the above EAAs but was less effective than thiamylal and did not significantly reduce [Ca2+]i that resulted from membrane depolarization with KCl. Pentobarbital, while differing from secobarbital by only a methyl group, was without effect on either the NMDA- or 40 mM KCl-induced elevations of [Ca2+]i. By contrast, cyproheptadine, a compound that has been shown to block Ca2+ channels, has a different profile from the above barbiturates in that cyproheptadine is more effective in blocking elevation of [Ca2+]i induced by membrane depolarization with KCl while the barbiturates are more effective in reducing [Ca2+]i induced by EAAs. An anticonvulsant barbiturate, phenobarbital, did not reduced elevations of [Ca2+]i induced by any EAA tested or by membrane depolarization with KCl. When cells were treated chronically with thiamylal for 4 days, 2-6 h after the abrupt drug withdrawal there was a hyperresponsiveness to the elevations of [Ca2+]i induced by both kainate and NMDA but not by quisqualate. A similar hyperresponsiveness was not seen after the chronic treatment with phenobarbital.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334512     DOI: 10.1016/0006-8993(93)90501-d

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  A Fatal Adverse Effect of Barbiturate Coma Therapy: Dyskalemia.

Authors:  Hyun Mook Kwon; Jin Wook Baek; Sang Pyung Lee; Jae Ik Cho
Journal:  Korean J Neurotrauma       Date:  2016-10-31

2.  The effect of barbiturate coma therapy for the patients with severe intracranial hypertension: a 10-year experience.

Authors:  Young-Il Kim; Seung-Won Park; Taek-Kyun Nam; Yong-Sook Park; Byung-Kook Min; Sung-Nam Hwang
Journal:  J Korean Neurosurg Soc       Date:  2008-09-30

3.  Pentobarbitone modulation of NMDA receptors in neurones isolated from the rat olfactory brain.

Authors:  P Charlesworth; I Jacobson; C D Richards
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Early prediction of neurological outcome after barbiturate coma therapy in patients undergoing brain tumor surgery.

Authors:  Jeong-Am Ryu; Wonkyung Jung; Yoo Jin Jung; Do Yeon Kwon; Kina Kang; Hyeok Choi; Doo-Sik Kong; Ho Jun Seol; Jung-Il Lee
Journal:  PLoS One       Date:  2019-04-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.